CasNo.14464-31-4,Hexadecanoic acid,2,5-dioxo-1-pyrrolidinyl ester,(14464-31-4) Suppliers

1 Kilogram	Negotiable

Min.Order :1 Kilogram
Purity: ≥95%
Payment Terms : L/C,D/A,D/P,T/T,MoneyGram,Other

Keywords

Liraglutide intermediate N-SUCCINIMIDYL PALMITATE HEXADECANOIC ACID-NHSE

Quick Details

Appearance:white power
Application:medical intermediate
PackAge:inside:double PE bag Outside: paper drum
ProductionCapacity:more than 50|Kilogram|Month
Storage:away from light, room temperature
Transportation:CIF by air or DAP by courier, FOB,EX works etc.

Superiority:

We have produced this product many years and now got scale production .Purity can reach more than 98%.

The Corporation's main product are high purity single molecular PEG series derivatives, hydroxyproline series derivatives, polypeptide long acting drug side chain and its intermediates (including Semaglutide side chain, liraglutide side chain, Degu insulin side chain, long-acting production hormone, etc.), and short peptide drugs modified side chains (semaglutide dipeptide, tetrapeptide).

Our company is working with innovative pharmaceutical companies to build a platform for research and development of polypeptide long-acting drugs, and is committed to building a systematic and diverse long-acting side chain library, establishing molecular blocks of polypeptide long-acting side chains, and providing various development solutions for customers to develop polypeptide long-acting drugs.

Details:

We have produced this product many years and now got scale production .Purity can reach more than 98%.

The Corporation's main product are high purity single molecular PEG series derivatives, hydroxyproline series derivatives, polypeptide long acting drug side chain and its intermediates (including Semaglutide side chain, liraglutide side chain, Degu insulin side chain, long-acting production hormone, etc.), and short peptide drugs modified side chains (semaglutide dipeptide, tetrapeptide).

Our company is working with innovative pharmaceutical companies to build a platform for research and development of polypeptide long-acting drugs, and is committed to building a systematic and diverse long-acting side chain library, establishing molecular blocks of polypeptide long-acting side chains, and providing various development solutions for customers to develop polypeptide long-acting drugs.